Results 61 to 70 of about 22,604 (146)
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021 Coronavirus disease 2019 (COVID‐19) is an infectious disease caused by severe acute respiratory syndrome coronavirus‐2, which has posed a significant threat to global health.
Luis Ortega‐Paz +3 more
doaj +1 more source
Asthma, severe acute respiratory syndrome coronavirus-2 and coronavirus disease 2019
Current Opinion in Allergy & Clinical Immunology, 2021 Purpose of review In December 2019, a novel respiratory illness caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first described and named coronavirus disease 2019 (COVID-19). Although the knowledge base surrounding COVID-19 and SARS-CoV-2 has grown rapidly, significant gaps in our knowledge remain and
Timberlake, Dylan T. +2 more
openaire +3 more sources
Undocumented Migrants Reintroducing COVID-19, Yunnan Province, China
Emerging Infectious Diseases, 2021 To limit the spread of severe acute respiratory syndrome coronavirus 2, the government of China has been monitoring infected travelers and minimizing cold-chain contamination. However, other factors might contribute to recurring outbreaks. We analyze the
Meiling Zhang +13 more
doaj +1 more source
Journal of Medical Case Reports, 2021 Background Hydroxychloroquine and chloroquine have been used for hospitalized coronavirus disease 2019 patients because of their antiviral and anti-inflammatory function.
Astrid Muyldermans +9 more
doaj +1 more source
SARS-CoV-2 Infection among Pregnant and Postpartum Women, Kenya, 2020–2021
Emerging Infectious Diseases, 2021 We determined incidence of severe acute respiratory syndrome coronavirus 2 and influenza virus infections among pregnant and postpartum women and their infants in Kenya during 2020–2021.
Nancy A. Otieno +6 more
doaj +1 more source
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): a review [PDF]
Molecular Cancer, 2020 AbstractIn recent years, the prevalence and spread of coronavirus has had a huge impact on global public health. Due to the incomplete understanding of the pathogenic mechanism of the virus, it is difficult for humans to fight against the virus quickly and effectively once the outbreak occurs. In early 2020, a novel coronavirus was discovered in Wuhan,
Feng Wang +3 more
openaire +4 more sources
The global emergence of severe acute respiratory syndrome coronavirus 2 in human [PDF]
VirusDisease, 2020 Coronaviruses are spherical and enveloped RNA viruses that infect diverse vertebrates like mammals, birds and fish. There are five human coronavirus species and all of their origin is linked to animal like bat and rodent. The two coronavirus species, Middle East respiratory syndrome-related coronavirus and Severe acute respiratory syndrome-related ...
openaire +3 more sources
Rhabdomyolysis as Potential Late Complication Associated with COVID-19
Emerging Infectious Diseases, 2020 We describe a patient in Wuhan, China, with severe acute respiratory syndrome coronavirus 2 infection who had progressive pulmonary lesions and rhabdomyolysis with manifestations of lower limb pain and fatigue.
Min Jin, Qiaoxia Tong
doaj +1 more source
SAGE Open Medical Case Reports, 2021 Since its first appearance in Wuhan, China, severe acute respiratory syndrome coronavirus 2 has rapidly spread throughout the world and has become a global pandemic.
Aimei Liu +8 more
doaj +1 more source
Genomic Epidemiology of Severe Acute Respiratory Syndrome Coronavirus 2, Colombia [PDF]
Emerging Infectious Diseases, 2020 Coronavirus disease (COVID-19) in Colombia was first diagnosed in a traveler arriving from Italy on February 26, 2020. However, limited data are available on the origins and number of introductions of COVID-19 into the country. We sequenced the causative agent of COVID-19, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), from 43 clinical ...
Katherine Laiton‐Donato +16 more
openaire +7 more sources